it through the various stages of preclinical and clinical evaluation to establish safety and efficacy. Submitting a bioequivalence study along with regulatory dossier is one of the requirements for product registration in most of the countries and pharma companies always look for a right partner who can help them in conduct of these studies in cost effective and timely manner
Premium Pharmacology Pharmacokinetics Clinical trial
SIM CARD A Subscriber Identity Module (SIM) card is a portable memory chip used mostly in cell phones that operate on the Global System for Mobile Communications (GSM) network. These cards hold the personal information of the account holder‚ including his or her phone number‚ address book‚ text messages‚ and other data. When a user wants to change phones‚ he or she can usually easily remove the card from one handset and insert it into another. SIM cards are convenient and popular with many users
Free Mobile phone GSM Subscriber Identity Module
Big Pharma funds 60 percent of all clinical trials‚ and it takes advantage of the power to persuade researchers and influence institutions. The byproducts of industry cover ups are massive numbers of deaths corresponding with millions of dollars in industry profits. Big Pharma is also responsible for killing more people than motor vehicle accidents. According to the Centers for Disease Control
Premium Political philosophy Sociology Science
Nutraceuticals Ltd. Square Pharmaceuticals Ltd. Type - Ltd Industry - Pharmaceutical Founded - 195 Headquarters - Pabna‚ Dhaka‚ Bangladesh Key people - Samson H. Chowdhury Website - http://www.squarepharma.com.bd/ Corporate History of Square Pharma The company was founded in 1958 by Samson H. Chowdhury along with three of his friends as a private firm. It went public in 1991 and is currently listed on the Dhaka Stock Exchange. Square Pharmaceuticals Ltd.‚ the flagship company‚ is holding the
Premium Corporation Initial public offering
culture of Ranbaxy Lab. To find out the promotional strategies used by Ranbaxy with respect to ‘Histac’ tab. To find out various promotional strategies used by Ranbaxy to acquire market share in Nagpur city. To study the competitors of ‘Histac’ in pharma market. To study the perceptions of Doctors on sales of ‘Histac’ LIMITATIONS:The scope of study is limited to Nagpur City only. There may be discrepancies in the actual data and the recorded data due to misinterpretations. Topic is vast
Premium Generic drug Pharmaceutical industry Gastroesophageal reflux disease
ZENITH International Journal of Multidisciplinary Research __________________ISSN 2231-5780 Vol.3 (1)‚ January (2013) Online available at zenithresearch.org.in PROFITABLITY PERFORMANCE ANALYSIS OF INDIAN PHARMA SECTOR T.NARAYANA GOWD*; DR.C.BHANU KIRAN**; DR.CH.RAMA PRASADA RAO** * Research Scholar (Part-time)‚ SKIM‚ S.K.University‚ Anantapur &Associate Professor‚ Srikalahastiswara Institute of Information and Management Sciences‚ Kapuganneri (village)‚ Srikalahasti( Mandal)‚ Chitoor
Premium Pharmacology Management Medicine
References: Axcan Pharma. (2010). Product update: Questions and answers. Retrieved August 21‚ 2010 from http://www.axcan.com/patient_product_qa.php?lang=1. FDA. (2010). About the FDA organization charts. Retrieved August 20‚ 2010 from http://www.fda.gov/AboutFDA/CentersOffices/OrganizationCharts/default
Premium Food and Drug Administration Pharmacology Pharmaceutical drug
pharmaceutical companies. ~ BPL supplies more than 10% of country’s total medicine need. ~ It offers top notch product quality and has world-class manufacturing facilities. ~ BPL is the recipient of three times µgold¶ national export trophy‚ Beximco Pharma is the largest exporter of pharmaceuticals from Bangladesh. Background of the Company« ~ Mission: BPL¶s mission is to ensure that each of the activities of the company benefits and adds value to the common wealth of our society. Vision: Viewing
Premium Pharmaceutical industry Tax Balance sheet
| 1.Introduction | | 1.1 Purpose and scope of the project | 6 | 1.2 Methodology | 7 | 1.3 Limitation of study | 8 | 1.4 Literature Review | 8 | 2.Industry profile | | 2.1 The Global Pharma market | 9 | 2.2 The Indian Pharma market | 9 | 3.Ratio Analysis | 11 | 4.Working capital management | 12 | 5.Phase І : Net Operating Cycle | | 5.1 Operating cycle Ankleshwar unit | 13 | 5.2 Operating cycle Dhabasa unit | 15 | 5.3 Major API Companies
Premium Inventory Working capital Cash conversion cycle
INTRODUCTION TO EQUITY VALUATION Equity shares can be described more easily than fixed income securities. However‚ they are more difficult to analyse. Fixed income securities typically have a limited life and a well-defined cash flow stream. Equity shares have neither. While the basic principles of valuation are the same for fixed income securities as well as equity shares‚ the factors of growth and risk create greater complexity in the case of equity shares . As our discussion
Premium Stock market Stock